A citation-based method for searching scientific literature

Jessica L Reed, Allison C Nugent, Maura L Furey, Joanna E Szczepanik, Jennifer W Evans, Carlos A Zarate. Biol Psychiatry Cogn Neurosci Neuroimaging 2019
Times Cited: 20







List of co-cited articles
219 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration.
Jennifer W Evans, Joanna Szczepanik, Nancy Brutsché, Lawrence T Park, Allison C Nugent, Carlos A Zarate. Biol Psychiatry 2018
80
50

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression.
Jessica L Reed, Allison C Nugent, Maura L Furey, Joanna E Szczepanik, Jennifer W Evans, Carlos A Zarate. Neuroimage Clin 2018
31
50

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
J W Murrough, K A Collins, J Fields, K E DeWilde, M L Phillips, S J Mathew, E Wong, C Y Tang, D S Charney, D V Iosifescu. Transl Psychiatry 2015
61
50

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
45

Ketamine Treatment and Global Brain Connectivity in Major Depression.
Chadi G Abdallah, Lynnette A Averill, Katherine A Collins, Paul Geha, Jaclyn Schwartz, Christopher Averill, Kaitlin E DeWilde, Edmund Wong, Alan Anticevic, Cheuk Y Tang,[...]. Neuropsychopharmacology 2017
154
40

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
40

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects.
Allison C Nugent, Elizabeth D Ballard, Todd D Gould, Lawrence T Park, Ruin Moaddel, Nancy E Brutsche, Carlos A Zarate. Mol Psychiatry 2019
104
30

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
882
30

A new depression scale designed to be sensitive to change.
S A Montgomery, M Asberg. Br J Psychiatry 1979
30

Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.
Chadi G Abdallah, Christopher L Averill, Ramiro Salas, Lynnette A Averill, Philip R Baldwin, John H Krystal, Sanjay J Mathew, Daniel H Mathalon. Biol Psychiatry Cogn Neurosci Neuroimaging 2017
71
25

Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity.
Roselinde H Kaiser, Jessica R Andrews-Hanna, Tor D Wager, Diego A Pizzagalli. JAMA Psychiatry 2015
25

Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A Luckenbaugh, Mark J Niciu, Dawn F Ionescu, Neal M Nolan, Erica M Richards, Nancy E Brutsche, Sara Guevara, Carlos A Zarate. J Affect Disord 2014
166
25

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.
Nancy Diazgranados, Lobna Ibrahim, Nancy E Brutsche, Andrew Newberg, Phillip Kronstein, Sami Khalife, William A Kammerer, Zenaide Quezado, David A Luckenbaugh, Giacomo Salvadore,[...]. Arch Gen Psychiatry 2010
673
25

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
Carlos A Zarate, Nancy E Brutsche, Lobna Ibrahim, Jose Franco-Chaves, Nancy Diazgranados, Anibal Cravchik, Jessica Selter, Craig A Marquardt, Victoria Liberty, David A Luckenbaugh. Biol Psychiatry 2012
515
25

Ketamine normalizes subgenual cingulate cortex hyper-activity in depression.
Laurel S Morris, Sara Costi, Aaron Tan, Emily R Stern, Dennis S Charney, James W Murrough. Neuropsychopharmacology 2020
41
25

Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial.
Jennifer L Phillips, Sandhaya Norris, Jeanne Talbot, Meagan Birmingham, Taylor Hatchard, Abigail Ortiz, Olabisi Owoeye, Lisa A Batten, Pierre Blier. Am J Psychiatry 2019
156
20

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
776
20

Ketamine, but Not the NMDAR Antagonist Lanicemine, Increases Prefrontal Global Connectivity in Depressed Patients.
Chadi G Abdallah, Arpan Dutta, Christopher L Averill, Shane McKie, Teddy J Akiki, Lynnette A Averill, J F William Deakin. Chronic Stress (Thousand Oaks) 2018
40
20

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.
James W Murrough, Andrew M Perez, Sarah Pillemer, Jessica Stern, Michael K Parides, Marije aan het Rot, Katherine A Collins, Sanjay J Mathew, Dennis S Charney, Dan V Iosifescu. Biol Psychiatry 2013
483
20

Modulation of amygdala reactivity following rapidly acting interventions for major depression.
Joana R A Loureiro, Amber Leaver, Megha Vasavada, Ashish K Sahib, Antoni Kubicki, Shantanu Joshi, Roger P Woods, Benjamin Wade, Eliza Congdon, Randall Espinoza,[...]. Hum Brain Mapp 2020
21
20

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Lace M Riggs, Jaclyn N Highland, Polymnia Georgiou, Edna F R Pereira, Edson X Albuquerque, Craig J Thomas, Carlos A Zarate,[...]. Pharmacol Rev 2018
427
20

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Jaskaran B Singh, Maggie Fedgchin, Kimberly Cooper, Pilar Lim, Richard C Shelton, Michael E Thase, Andrew Winokur, Luc Van Nueten, Husseini Manji,[...]. JAMA Psychiatry 2018
296
20

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression.
Carlos A Zarate, Nancy Brutsche, Gonzalo Laje, David A Luckenbaugh, Swarajya L Vattem Venkata, Anuradha Ramamoorthy, Ruin Moaddel, Irving W Wainer. Biol Psychiatry 2012
191
20

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
719
20

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).
Maurizio Fava, Marlene P Freeman, Martina Flynn, Heidi Judge, Bettina B Hoeppner, Cristina Cusin, Dawn F Ionescu, Sanjay J Mathew, Lee C Chang, Dan V Iosifescu,[...]. Mol Psychiatry 2020
143
20

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
J H Krystal, L P Karper, J P Seibyl, G K Freeman, R Delaney, J D Bremner, G R Heninger, M B Bowers, D S Charney. Arch Gen Psychiatry 1994
20

The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: A randomized controlled study.
Cheng-Ta Li, Mu-Hong Chen, Wei-Chen Lin, Chen-Jee Hong, Bang-Hung Yang, Ren-Shyan Liu, Pei-Chi Tu, Tung-Ping Su. Hum Brain Mapp 2016
75
20

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.
Chadi G Abdallah, Henk M De Feyter, Lynnette A Averill, Lihong Jiang, Christopher L Averill, Golam M I Chowdhury, Prerana Purohit, Robin A de Graaf, Irina Esterlis, Christoph Juchem,[...]. Neuropsychopharmacology 2018
98
20

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
Allison C Nugent, Nancy Diazgranados, Paul J Carlson, Lobna Ibrahim, David A Luckenbaugh, Nancy Brutsche, Peter Herscovitch, Wayne C Drevets, Carlos A Zarate. Bipolar Disord 2014
59
20

Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
Rebecca McMillan, Rachael Sumner, Anna Forsyth, Doug Campbell, Gemma Malpas, Elizabeth Maxwell, Carolyn Deng, John Hay, Rhys Ponton, Frederick Sundram,[...]. Prog Neuropsychopharmacol Biol Psychiatry 2020
19
21

Increased Reactivity of the Mesolimbic Reward System after Ketamine Injection in Patients with Treatment-resistant Major Depressive Disorder.
Virginie Sterpenich, Sonia Vidal, Jeremy Hofmeister, Giorgio Michalopoulos, Victor Bancila, Delphine Warrot, Alexandre Dayer, Martin Desseilles, Jean-Michel Aubry, Markus Kosel,[...]. Anesthesiology 2019
24
20

Synaptic dysfunction in depression: potential therapeutic targets.
Ronald S Duman, George K Aghajanian. Science 2012
819
20

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
20


7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study.
Jennifer W Evans, Níall Lally, Li An, Ningzhi Li, Allison C Nugent, Dipavo Banerjee, Sam L Snider, Jun Shen, Jonathan P Roiser, Carlos A Zarate. Neuropsychopharmacology 2018
17
17

Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder.
Allison C Nugent, Cristan Farmer, Jennifer W Evans, Sam L Snider, Dipavo Banerjee, Carlos A Zarate. Hum Brain Mapp 2019
24
15


Test-retest reliability of evoked BOLD signals from a cognitive-emotive fMRI test battery.
Michael M Plichta, Adam J Schwarz, Oliver Grimm, Katrin Morgen, Daniela Mier, Leila Haddad, Antje B M Gerdes, Carina Sauer, Heike Tost, Christine Esslinger,[...]. Neuroimage 2012
206
15

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.
Jaskaran B Singh, Maggie Fedgchin, Ella J Daly, Peter De Boer, Kimberly Cooper, Pilar Lim, Christine Pinter, James W Murrough, Gerard Sanacora, Richard C Shelton,[...]. Am J Psychiatry 2016
278
15

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.
N Lally, A C Nugent, D A Luckenbaugh, R Ameli, J P Roiser, C A Zarate. Transl Psychiatry 2014
161
15

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
384
15

Convergent Mechanisms Underlying Rapid Antidepressant Action.
Panos Zanos, Scott M Thompson, Ronald S Duman, Carlos A Zarate, Todd D Gould. CNS Drugs 2018
97
15

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini Manji,[...]. Am J Psychiatry 2018
223
15

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature.
Dawn F Ionescu, Julia M Felicione, Aishwarya Gosai, Cristina Cusin, Philip Shin, Benjamin G Shapero, Thilo Deckersbach. Harv Rev Psychiatry 2018
47
15


Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Madhukar H Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, Anna R Duca, David Hough,[...]. JAMA Psychiatry 2019
190
15

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.
Elizabeth D Ballard, Dawn F Ionescu, Jennifer L Vande Voort, Mark J Niciu, Erica M Richards, David A Luckenbaugh, Nancy E Brutsché, Rezvan Ameli, Maura L Furey, Carlos A Zarate. J Psychiatr Res 2014
159
15

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
257
15

Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine.
Matti Gärtner, Sabine Aust, Malek Bajbouj, Yan Fan, Katja Wingenfeld, Christian Otte, Isabella Heuser-Collier, Heinz Böker, Josef Hättenschwiler, Erich Seifritz,[...]. Eur Neuropsychopharmacol 2019
32
15

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).
Maggie Fedgchin, Madhukar Trivedi, Ella J Daly, Rama Melkote, Rosanne Lane, Pilar Lim, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Michael Liebowitz,[...]. Int J Neuropsychopharmacol 2019
162
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.